skip to Main Content
 

Kevin Kissling Joins Avalere Health, Expands End-to-End Market Solutions

  • This page as PDF

Summary

He brings significant experience in 3PL, channel and distribution strategies, and innovative market access solutions for life sciences companies to expedite product to patient.

Kevin will be joining Avalere’s Market Access team as a Senior Consultant. He will be working with life sciences companies and others in the supply chain that are critical partners for commercialization.

“COVID-19 has created tremendous opportunity for change in how we think about traditional, trade, distribution, and specialty strategies,” said Lance Grady, Practice Director at Avalere. “Kevin brings a wealth of distribution knowledge to the firm and nicely rounds out our end-to-end market access capabilities.”

Kevin previously worked at McKesson where he held multiple roles during his 13-year tenure at the company.  Most recently, he served as the Vice President of their third-party logistics division, RxCrossroads by McKesson, where he had general management responsibility to include defining and communicating the business vision, mission, strategy, plan, target markets and culture.

Kevin previously led the vaccines group within the McKesson Specialty Health team where he designed the business growth strategy and developed marketing, education, and sales incentive plans. Kevin was also responsible for McKesson’s overall relationship with The Centers for Disease Control and Prevention (CDC) in support of McKesson’s centralized distribution contract with the CDC. He also sat on McKesson’s executive leadership team with overall responsibility for IT functions in support of the H1N1 pandemic response which included warehousing and distributing over 125M doses of H1N1 flu vaccine.

“I’m excited to join Avalere’s Market Access team during this dynamic time in healthcare,” said Kevin Kissling, Senior Consultant at Avalere. “Avalere’s access to robust data assets is unmatched in the market and are exactly what manufacturers need to develop thoughtful, evidence-based commercialization strategies.”

To receive Avalere updates, connect with us.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top